3-HO-PCP
3-HO-PCP is a dissociative anesthetic drug that has been sold online as a designer drug. The compound was first synthesized in 1978 to investigate the structure-activity relationship of phencyclidine derivatives. The activity of 3-HO-PCP in humans was not described until 1999 when a chemist using the pseudonym John Q. Beagle reported qualitative similarities to PCP.
Chemistry[edit | edit source]
3-HO-PCP is an arylcyclohexylamine derivative and shares many features with other substances of this class. It is closely related to 3-MeO-PCP and PCP.
Pharmacology[edit | edit source]
As with other arylcyclohexylamine derivatives, the pharmacological action of 3-HO-PCP is believed to result primarily from NMDA receptor antagonism. Other factors, such as opioid receptor affinity could potentially be involved in the drug's effects.
Effects[edit | edit source]
The effects of 3-HO-PCP can vary greatly depending on the dose, but may include dissociation, hallucinations, analgesia, sedation, amnesia, and euphoria. It is often described as being more potent than PCP.
Legality[edit | edit source]
3-HO-PCP is illegal in many countries due to its potential for abuse and health risks. It is classified as a Schedule I substance in the United States.
See also[edit | edit source]
3-HO-PCP Resources | ||
---|---|---|
|
|
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD